Dairy manure as a potential source of crop nutrients and environmental contaminants

Although animal manure is applied to agricultural fields for its nutrient value, it may also contain potential contaminants. To determine the variability in such contaminants as well as in valuable nutrients, nine uncomposted manure samples from Idaho dairies collected during 2.5 years were analyzed for macro- and micro-nutrients, hormones, phytoestrogens, antibiotics, veterinary drugs, antibiotic resistance genes, and genetic elements involved in the spread of antibiotic resistance. Total N ranged from 6.8 to 30.7 (C:N of 10 to 21), P from 2.4 to 9.0, and K from 10.2 to 47.7 g/kg manure. Zn (103 – 348 mg/kg) was more abundant than Cu (56 – 127 mg/kg) in all samples. Phytoestrogens were the most prevalent contaminants detected, with concentrations fluctuating over time, reflecting animal diets. This is the first study to document the presence of flunixin, a non-steroidal anti-inflammatory drug, in solid stacked manure from regular dairy operations. Monensin was the most frequently detected antibiotic. Progesterones and sulfonamides were regularly detected. We also investigated the relative abundance of several types of plasmids involved in the spread of antibiotic resistance in clinical settings. Plasmids belonging to the IncI, IncP, and IncQ1 incompatibility groups were found in almost all manure samples. IncQ1 plasmids, class 1 integrons, and sulfonamide resistance genes were the most widespread and abundant genetic element surveyed, emphasizing their potential role in the spread of antibiotic resistance. The benefits associated with amending agricultural soils with dairy manure must be carefully weighed against the potential negative consequences of any manure contaminants.     

Product identification and toxicity change during oxidation of methotrexate by ferrate and permanganate in water

• Oxidation of methotrexate by high-valent metal-oxo species was first explored. • Fe(VI) presented a higher reactivity to MTX than Mn(VII) at pH 8.0. • Ketonization and cleavage of peptide bond were two initial reaction pathways. • Products of MTX were not genotoxic, neurotoxic, or endocrine-disrupting chemicals. • The less biodegradable products exhibited developmental and acute/chronic toxicity. Accompanying an annual increase in cancer incidence, the global use of anticancer drugs has remarkably increased with their worldwide environmental prevalence and ecological risks. In this study, the oxidation of methotrexate (MTX), a typical anticancer drug with ubiquitous occurrence and multi-endpoint toxicity, by ferrate(VI) (Fe(VI)) and permanganate (Mn(VII))) was investigated in water. Fe(VI) exhibited a higher reactivity with MTX (93.34 M⁻¹ s⁻¹) than Mn(VII) (3.01 M⁻¹ s⁻¹) at pH 8.0. The introduction of Cu(II) and Fe(III) at 1.0 mM improved the removal efficiency of 5.0 μM MTX by 100.0 μM Fe(VI) from 80% to 95% and 100% after 4 min, respectively. Seven oxidized products (OPs) were identified during oxidative treatments, while OP-191 and OP-205 were characterized as specific products for Fe(VI) oxidation. Initial ketonization of the L-glutamic acid moiety and cleavage of the peptide bond of MTX were proposed. Additionally, a multi-endpoint toxicity evaluation indicated no genotoxicity, neurotoxicity, or endocrine-disrupting effects of MTX and its OPs. Particularly, serious developmental toxicity in zebrafish larvae was observed in the treated MTX solutions. Based on the acute and chronic aquatic toxicity prediction, OP-190, OP-192, OP-206, and OP-208 were deemed toxic or very toxic compared to harmful MTX. Furthermore, the reduced biodegradability index from 0.15 (MTX) to −0.5 to −0.2 (OP-192, OP-206, and OP-468) indicated the formation of lower biodegradable OPs. Overall, this study suggests that Fe(VI) and Mn(VII) oxidation are promising treatments for remediating anticancer drug-contaminated water. However, the environmental risks associated with these treatments should be considered in the evaluation of water safety.     

兽用抗生素在土壤环境中的行为及其生态毒理效应研究进展

目前全球至少有70%左右的抗生素被用于畜牧业和水产养殖业,这些抗生素大多不能被动物完全吸收,以母体或代谢物的形式排出动物体外的抗生素约占用药量的40～90%,排出体外的抗生素大多随粪便等进入环境尤其是土壤环境中并在其中累积.为了明确兽用抗生素对环境中生物等的影响,合理评价兽用抗生素的环境风险,论文就土壤环境中兽用抗生素的来源,兽用抗生素在土壤环境中的吸附、迁移、降解以及对环境中生物的影响等方面进行了综述,在此基础上提出了今后的重点研究方向.     

兽药抗生素对生态环境的混合毒性研究进展

抗生素是环境中普遍存在的污染物,畜牧水产养殖是其主要来源之一.环境中可能同时存在多种抗生素残留,因此单一药物的毒性评价难以反映抗生素对生态环境的影响,应探究其混合物的毒性效应.本文在总结大量文献的基础上,介绍了兽用抗生素的残留现状,总结了兽用抗生素对生态环境的混合毒性研究进展,讨论了兽用抗生素残留对土壤生物和水生生物的...     

成瘾者头发样品中滥用药物的GC—MS鉴定

本文采用气相色谱－质谱方法分离、鉴定成瘾者头发样品中的滥用药物，样品处理方法简单，甲醇一次超声提取，提取效果较好，样品用量少，仅需２０ｍｇ。应用该法对几例成瘾者头发样品进行了分析鉴定，不公检出几种代谢产物，而且检出药物的原形。     

粉葛根腐病菌的生物学特性及防治研究

粉葛根腐病是粉葛生产上新发现的一种毁灭性土传病害。作者对病原作了人工分离和接菌试验，观测了温度、pH对病原菌菌丝体生长的影响；对防治药剂进行了筛选和试验，探讨了该病的有效防治药物及对策。     

双氯芬酸和醋氨酚对稀有鮈鲫早期生活阶段的毒性效应

随着非甾体抗炎药（NSAIDs）的持续使用与排放,世界各地的地表水、海水、地下水、污水厂进出水中均已频繁检测到该类药物,这对生态系统中各种非靶标生物造成了一定威胁.本研究评价了两种典型的非甾体抗炎药-双氯芬酸（Diclofenac）和醋氨酚（Acetaminophen）对中国特有物种稀有鮈鲫（Gobiocypris rarus）早期生活阶段的毒性效应.实验结果显示,醋氨酚的毒性较弱,当浓度达到48.4 mg·L^-1（NOEC）时,稀有鮈鲫的孵化率、死亡率、异常率、全长和干重均未表现出明显的中毒症状;而双氯酚酸的毒性则较强,当浓度达17.8 mg·L^-1（LC₁₀）时,即可导致稀有鮈鲫孵化率下降,当浓度达到10.2 mg·L^-1（LOEC）时,即可造成幼鱼外观和行为的显著异常,表明双氯芬酸对稀有鮈鲫的孵化和生长均产生了一定的致毒效应.同时,根据稀有鮈鲫和几种常用模式生物之间的孵化率、孵化后存活率、体长和双氯芬酸敏感性的比较结果,可认为稀有鮈鲫适用于污染物对鱼类早期生活阶段毒性效应的评估.     

北京市城市河流中精神活性物质的污染水平及环境风险

为评价北京市城市河流地表水体中5种精神活性物质〔METH(甲基苯丙胺)、AMP(苯丙胺)、KET(氯胺酮)、EPH(麻黄碱)和HA(羟亚胺)〕的环境风险,通过对固相萃取柱(Oasis HLB、Oasis MCX、Oasis WAX和Oasis PRiME HLB)类型、水样酸化、洗脱剂类型及体积等条件的确定,建立了同时测定水环境中精神活性物质的固相萃取-液相色谱-质谱(SPE-LC-MS/MS)联用方法,并对北京市城市河流地表水体中5种精神活性物质的质量浓度水平进行了调查,采用RQ(风险熵)法进行了风险评价. 结果表明,在水样未酸化条件下,Oasis MCX柱对精神活性物质的回收率最高,使用含5%(V/V)氨水的甲醇作为洗脱液,5种精神活性物质的回收率可以达到81.8%~91.1%. 地表水水体基质加标结果表明,5种精神活性物质的加标回收率均大于75.5%,相对标准偏差均小于10.0%. 方法检出限为0.30~0.80 ng/L,定量限为1.00~2.68 ng/L. 北京市7条城市河流中5种精神活性物质的质量浓度在1.00~99.51 ng/L之间. EPH在所有采样点均被检出且质量浓度较高,ρ(EPH)平均值为22.79 ng/L;ρ(AMP)相对较低,在1.54~11.23 ng/L之间,但AMP检出率为97.06%;ρ(METH)较高,平均值为14.63 ng/L,最高值(99.51 ng/L)出现在坝河. 研究显示,北京市地表水中5种精神活性物质的RQ均小于0.1,表明其可能的环境风险较低,但由于精神活性物质本身具有生物活性,它们对城市河流水生生态系统产生的潜在危害不容忽视.      

Predicting categories of drugs used by suspected drug-impaired drivers using the Drug Evaluation and Classification Program tests

Objective: The purpose of this study was to statistically determine which combination(s) of drug-related signs and symptoms from the Drug Evaluation and Classification (DEC) protocol best predict the drug category used by the suspected drug-impaired driver.

Methods: Data from 1,512 completed DEC evaluations of suspected impaired drivers subsequently found to have ingested central nervous system (CNS) depressants, CNS stimulants, narcotic analgesics, and cannabis were analyzed using a multinomial logistic regression procedure. A set of evaluations completed on drug-free subjects was also included. The relative importance of clinical, behavioral, and observational measures in predicting drug categories responsible for impairment was also examined.

Results: Thirteen drug-related indicators were found to significantly contribute to the prediction of drug category, including being under the care of a doctor or dentist, condition of the eyes, condition of the eyelids, mean pulse rate, assessment of horizontal gaze nystagmus (HGN), convergence, performance on the One Leg Stand (OLS) Test, eyelid tremors, pupil size in darkness, reaction to light, presence of visible injection sites, systolic blood pressure, and muscle tone. Indicators related to the appearance and physiological response of the eye contributed the most to the prediction of drug category, followed closely by clinical indicators and performance on the psychophysical tests.

Conclusions: The findings from this study suggest that drug recognition experts (DREs) should be careful to review a set of key signs and symptoms when determining the category of drug used by suspected drug-impaired drivers. Drug use indicators related to the appearance and physiological response of the eye were found to contribute the most to the prediction of the drug category responsible for the impairment. These results could help form the basis of a core set of indicators that DREs could initially consult to form their opinion of drug influence. This in turn may enhance the validity, effectiveness, and efficiency of drug detection and identification by DREs and lead to a more effective and efficient DEC program, improved enforcement of drug-impaired driving, and greater acceptance of the DEC program by the courts.